Top Abstract Purchase Related
Home
>
Node
>
Subnode

Antisense oligonucleotide technology: from EST to therapeutics

Giles, R.V.

Current Opinion in Molecular Therapeutics 2(3): 238-252

2000

ISSN/ISBN: 1464-8431
PMID: 11249617
Document Number: 513911
The ability to selectively inhibit gene expression with antisense oligonucleotides could have profound effects upon future biological research, including functional genomics, and the ways in which many diseases are treated. This review describes cell culture-based research pertaining to the selection of optimal antisense effector sequences, their desired and non-antisense mechanisms of action and their delivery into the appropriate intracellular compartments. Preclinical and clinical use of antisense technology is examined and probable future directions that this may take are discussed. Overall, the current state of antisense oligonucleotide research described here promises a highly productive future for this technology.

Document emailed within 1 workday
Secure & encrypted payments

Witczak, Z.J. 2000: Oligonucleotide and carbohydrate therapeutics Idrugs: the Investigational Drugs Journal 3(6): 591-592
Yoshioka, K.; Kuwahara, H.; Nishina, K.; Nagata, T.; Yokota, T. 2015: Recent progress and prospect in oligonucleotide therapeutics Nihon Rinsho. Japanese Journal of Clinical Medicine 73(6): 1057-1065
Gewirtz, A.M. 1997: Developing oligonucleotide therapeutics for human leukemia Anti-Cancer Drug Design 12(5): 341-358
Liu, Y.; Yu, L.-l.; Cui, Y.-h.; Ji, Y.-x. 2005: Survivin antisense oligonucleotide induces human Hep-2 cell apoptosis Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 40(8): 571-574
Wang, X.-z.; Wang, S.-h.; Song, H.-f.; Wang, Q.-q.; Wang, S.-q. 2011: Pharmacokinetics of cantide, an antisense oligonucleotide, and its metabolites in rhesus monkeys Yao Xue Xue Bao 46(11): 1370-1373
Yang, B.; Sun, O.; Zhang, M.; Wang, S. 2004: Determination of antisense phosphorothioate oligonucleotide drug Cantide by capillary gel electrophoresis Se Pu 22(3): 202-205
Ho, P.T.; Parkinson, D.R. 1997: Antisense oligonucleotides as therapeutics for malignant diseases Seminars in Oncology 24(2): 187-202
Agathangelou, P. 1999: Division of Carbohydrate Chemistry--recent developments in oligonucleotide therapeutics Idrugs: the Investigational Drugs Journal 2(6): 519-520
Yu, B.W.; Nguyen, D.; Anderson, S.; Allegra, C.A. 1997: Phosphorothioated antisense c-myc oligonucleotide inhibits the growth of human colon carcinoma cells Anticancer Research 17(6d): 4407-4413
Geary, R.S.; Leeds, J.M.; Henry, S.P.; Monteith, D.K.; Levin, A.A. 1997: Antisense oligonucleotide inhibitors for the treatment of cancer: 1. Pharmacokinetic properties of phosphorothioate oligodeoxynucleotides Anti-Cancer Drug Design 12(5): 383-393
Castier, Y.; Chemla, E.; Chardigny, C.; Nierat, J.; Eudes, D.; Vasseur, M.A.; Bruneval, P.; Carpentier, A.; Fabiani, J.N. 1997: Effects on myointimal proliferation of an antisense oligonucleotide directed against c-myb: specificity of action and consequences on vasoreactivity Chirurgie; Memoires de l'Academie de Chirurgie 122(4): 260-267
Abramova, T.V.; Vlasov, V.V.; Ivanova, E.M.; Zarytova, V.F.; Fokina, T.N.; Frolova, E.I.; Iurchenko, L.V. 1994: Suppression of influenza virus NP-protein mRNA translation in vitro with derivatives of an antisense oligonucleotide Molekuliarnaia Biologiia 28(2): 307-312
Robbins, I.; Lebleu, B. 2000: Vesicular stomatitis virus as model system for studies of antisense oligonucleotide translation arrest Methods in Enzymology 313: 189-203
Cheng, Q.; Chen, X.; Ye, Y. 1999: Antisense oligonucleotide attenuates renal tubulointerstitial injury in mice with unilateral ureteral obstruction Zhonghua Yi Xue Za Zhi 79(7): 533-537
Fu, G.; Wang, G.-b.; Lu, X.-m.; Xia, Y.-c.; Yang, C.; Tian, Y.-l. 2005: Inhibitory effect against the gastric carcinoma cell growth by the combination of the survivin antisense oligonucleotide and P53 gene Zhonghua Wei Chang Wai Ke Za Zhi 8(5): 451-454
Fogel-Petrovic, M.; Vujcic, S.; Häner, R.; Regenass, U.; Mett, H.; Porter, C.W. 1996: Sequence specific antisense oligonucleotide analog interference with spermidine/spermine N1-acetyltransferase gene expression Anticancer Research 16(5a): 2517-2523
Li, Q.; Zhang, Y.-H.; Li, P.-L.; Pei, J.-R. 2008: Inhibitory effect of antisense oligonucleotide of integrin-linked kinase on cell proliferation of human epithelial ovarian cancer Zhonghua Fu Chan Ke Za Zhi 43(3): 218-222
Dvorchik, B.H.; Marquis, J.K. 2000: Disposition and toxicity of a mixed backbone antisense oligonucleotide, targeted against human cytomegalovirus, after intravitreal injection of escalating single doses in the rabbit Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(10): 1255-1261
Dean, N.; Mckay, R.; Miraglia, L.; Howard, R.; Cooper, S.; Giddings, J.; Nicklin, P.; Meister, L.; Ziel, R.; Geiger, T.; Muller, M.; Fabbro, D. 1996: Inhibition of growth of human tumor cell lines in nude mice by an antisense of oligonucleotide inhibitor of protein kinase C-alpha expression Cancer Research 56(15): 3499-3507
Han, J.; Sun, L.; Liang, H.; Cheng, Y. 2014: Effects of 12/15-lipoxygenase antisense oligonucleotide on peroxisome proliferator-activated receptor γ translocation in primarily cultured cortical neurons after oxygen-glucose deprivation Zhonghua Yi Xue Za Zhi 94(15): 1179-1183